Sector revisions AstraZeneca PLC

Equities

Market Closed - London S.E. Other stock markets 16:35:29 23/01/2026 GMT			5-day change	1st Jan Change
13,580.00 ^GBX	+0.15%		-3.18%	-1.52%

01:39pm	Seeking to boost UK economy, finance minister Reeves to accompany Starmer on China visit	RE
12:50pm	Ocular Therapeutix, Inc. Announces Chief Financial Officer Changes, Effective January 20, 2026	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ASTRAZENECA PLC							20
	ELI LILLY AND COMPANY							28
	JOHNSON & JOHNSON							24
	ABBVIE INC.							27
	ROCHE HOLDING AG							19
	NOVARTIS AG							20
	NOVO NORDISK A/S							21
	MERCK & CO., INC.							27
	AMGEN INC.							27
	GILEAD SCIENCES, INC.							26
	PFIZER INC.							24
	VERTEX PHARMACEUTICALS INCORPORATED							25
	SANOFI							22
	BRISTOL-MYERS SQUIBB COMPANY							23
	GSK PLC							19
	CHUGAI PHARMACEUTICAL CO., LTD.							14
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	BAYER AG							20
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	Average							22
	Weighted average by Cap.							24